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I I 
DURABILITY OF DONOR- 
SPECIFIC AND ORGAN- 
SPECIFIC HEART 
TRANSPLANT TOLERANCE 
INDUCED BY INTRATHYMIC 
PRETREATMENT WITH 
ALLOGENEIC SPLEEN CELLS 
Permanent acceptance ofan experimental cardiac allograft can be achieved 
in the rat by pretreating the recipient with antilymphocyte s rum and 
intrathymic donor lymphocytes. We investigated the durability and speci- 
ficity of the tolerance produced by this pretreatment in a rat model of 
heterotopic heart transplantation with Lewis-Brown Norway donors and 
Lewis recipients. Pretreated Lewis rats received 1ml antilymphocyte s rum 
intraperitoneaily and 5 x 10 7 Lewis-Brown Norway splenocytes intrathy- 
mically, followed 21 days later by Lewis-Brown Norway cardiac transplan' 
tation. The first Lewis-Brown Norway cardiac allograft survived long term 
(mean 140 days) in pretreated recipients who were given no subsequent 
immunosuppression. After 60 days with a beating Lewis-Brown Norway 
allograft, tolerant Lewis recipients underwent a second cardiac allograft 
with either a Lewis-Brown Norway heart or a third-party Wistar-Furth 
heart. The second Lewis-Brown Norway cardiac allograft was not rejected 
(mean survival 76 days), but that from the third-party Wistar-Furth donor 
was rejected in a normal fashion (mean survival 10.4 days). The presence 
of second grafts did not affect survival of first grafts. Tolerant Lewis 
recipients of two Lewis-Brown Norway heart grafts underwent subsequent 
transplantation with Lewis-Brown Norway skin. Skin allograft survival in 
this group (mean 8.4 days) was not different from that in Lewis recipients 
without pretreatment. Rejection of skin grafts had no effect on the heart 
grafts. These data suggest that tolerance to cardiac allografts produced by 
intrathymic pretreatment is durable and extends to a second heart graft 
from a genetically identical donor. Tolerant rats reject third-party hearts 
and primary donor skin grafts normally, and tolerance to previously placed 
heart grafts is not abrogated by this rejection. Non-major histocompati- 
bility complex skin antigens not present on cardiac cells may account for 
the tissue specificity of the tolerance produced by intrathymic treatment in
this model. (J THORAC CARDIOVASC SURG 1996;111:429-31) 
Zhenya Shen, MD, Muhammad Mohiuddin, MD, Charles Goldstein, MD, 
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O rgan transplantation is effective treatment for patients with end-stage organ failure. Success of 
heart transplantation between genetically disparate 
individuals, however, is currently dependent on 
long-term use of nonspecific immunosuppressive 
agents that cause significant morbidity and mortal- 
From the Department ofSurgery, Medical College of Pennsyl- 
vania and Hahnemann University, Philadelphia. 
Received for publication March 27, 1995. 
Accepted for publication May 23, 1995. 
Address for reprints: Verdi J. DiSesa, MD, Cardiothoracic 
Surgery, Medical College of Pennsylvania, 3300 Henry Ave., 
Philadelphia, PA 19129. 
Copyright © 1996 by Mosby-Year Book, Inc. 
0022-5223/96 $5.00 + 0 12/1/66458 
ity. The induction of donor-specific tolerance with- 
out the need for long-term nonspecific immunosup- 
pression has long been a goal of transplantation 
research. In previous experiments, we and others 
Showed that permanent acceptance of a heterotopic 
experimental cardiac allograft can be achieved in 
the rat by pretreating the recipient with antilympho- 
cyte serum (ALS) and donor-specific lymphocytes 
given intrathymically. 1-4A report by Nakafusa and 
colleagues, 5 however, suggested that this method 
fails to induce tolerance to renal and skin allografts. 
Major histocompatibility complex (MHC) antigens 
as well as other antigens were involved in the 
differential rejection of various organ allografts. 6 In 
these studies, we investigated the durability and 
specificity of the graft tolerance produced by intra- 
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Table I. Survival of  cardiac and skin grafts in Lewis rats 
Mean survival 
Pretreatment First graft Second graft Third graft Survivals (days) (days) 
None LBN heart None None 7, 7, 8, 8, 9 7.8 
None WF heart None None 8, 8, 9, 10, 10 9 
None LBN skin None None 6, 7, 8, 8, 9 7.6 
ALS and IT LBN cells LBN heart >100, >100, >100, >200, >200 140" 
LBN heart >60, >60, >60, >100, >100 76* 
LBN skin 7, 8, 8, 9, 10 8.4 
ALS and IT LBN cells LBN heart >100, >100, >150, >150, >150 130" 
WF heart None 8, 10, 10, 11, 13 10.4 
IT, Intrathymic. 
*p < 0.001 vs control (unpaired two-tailed t test). 
thymic pretreatment in an experimental model of 
allotransplantation. 
Materials and methods 
Animals. Mature male Lewis, Lewis-Brown Norway 
(LBN), and Wistar-Furth (WF) rats were obtained from 
Harlan Sprague-Dawley, Inc. (Indianapolis, Ind.). Ani- 
mals were acquired without viral infestation and were kept 
in an environment free of virus in the animal facility at 
Medical College of Pennsylvania Hospital. All animals 
were handled in a humane fashion and in accord with the 
"Principles of Laboratory Animal Care" formulated by 
the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
Publication No. 86-23, revised 1985). 
Experimental design. In these experiments, Lewis rats 
were recipients, LBN rats were donors of splenocytes, 
hearts, and skin, and WF rats were third-party heart 
donors. Lewis recipients were pretreated by intrathymic 
inoculation with LBN splenocytes plus ALS injected in- 
traperitoneally. LBN-to-Lewis cervical heterotopic heart 
transplantation was performed 21 days later. After 60 days 
with a beating cervical LBN heart, recipient animals were 
divided into two groups. In group A, tolerant Lewis 
recipients underwent a second, intraabdominal cardiac 
allograft with an LBN donor heart, then underwent 
subsequent transplantation with LBN skin after 60 days 
with two hearts. In group B, tolerant Lewis recipients 
underwent a second, intraabdominal cardiac allograft with 
a third-party WF donor heart. Control heart transplanta- 
tion with an LBN or WF donor and full-thickness kin 
transplantation with an LBN donor were carried out in 
untreated Lewis rats. Each group included five subjects. 
Preparation of donor spleen cells. Whole spleens were 
harvested from donor rats and disrupted by means of a 
tissue homogenizer. Erythrocytes were lysed with ammo- 
nium chloride. Remaining leukocytes were washed with 
RPMI 1640 medium (Sigma Chemical Co., St. Louis, 
Mo.). Viability of cells was evaluated by trypan-blue dye 
exclusion. 
Intrathymie inoculation of cellular alloantigen. On the 
day before intrathymic treatment, animals received 1 ml 
ALS intraperitoneally. The next day, after induction of 
methoxyflurane (metofane) inhalation anesthesia, the thy- 
mus of the recipient rat was exposed by a partial medial 
sternotomy and 2.5 × 107 donor splenocytes in a volume 
of 0.05 ml RPMI 1640 medium were injected into both 
lobes of the recipient hymus under direct vision. 
Heart transplantation. All procedures were done with 
the subjects under general anesthesia. Heterotopic ervi- 
cal cardiac transplants were performed with a suture 
technique, anastomosing the donor aorta and pulmonary 
artery to the recipient's internal carotid artery and jugular 
vein, respectively. 7 Heterotopic abdominal heart trans- 
plantation was performed with the modified technique of 
Ono and Lindsey, 8with the donor aorta and pulmonary 
artery anastomosed nd-to-side to the recipient's abdom- 
inal aorta and inferior vena cava, respectively. Cardiac 
allograft survival was determined by daily palpation and, if 
results of palpation were indeterminate, by direct visual- 
ization. Rejection was marked by the complete absence of 
ventricular contractions and was confirmed histologically. 
Skin grafting. Skin grafting was performed according 
to the method of Thornburg and associates. 9 Full-thick- 
ness skin was harvested and cleansed of subcutaneous 
tissue. The graft, measuring 3 × 3 cm, was sutured onto 
the flank of the recipient animal. Dressings were removed 
on postgrafting day 5, and grafts were inspected aily. 
Hair loss, epidermal breakdown, and ulceration were used 
as signs of rejection. More than 50% necrosis of the 
grafted surface area was considered complete rejection. 
Histopathology. Heart allografts were fixed in 10% 
buffered formalin, paraffin-embedded, sectioned, and 
stained with hematoxylin and eosin. Slides were examined 
by light microscopy. 
Statistical analysis. Comparison between groups was 
done with an unpaired, two-tailed Student's t test. 
Results 
Results of allograft survivals are summarized in 
Table I. Intrathymic inoculation of LBN splenocytes 
in conjunction with a single intraperitoneal dose of 
ALS produced essentially permanent (mean 140 days) 
tolerance to LBN hearts in Lewis recipients. This 
survival was significantly different (p < 0.01) from that 
in untreated Lewis recipients (mean 7.8 days). 
Tolerant Lewis rats with surviving LBN cardiac 
grafts (>60 days) did not reject either heart when 
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rechallenged with a second LBN heart, with second 
graft survival longer than 60 days (mean 76 days,p < 
0.01 vs control), but they did reject a third-party WF 
cardiac allograft in a normal fashion (mean 10.4 
days). Rejection of third-party donor grafts did not 
affect the survival of the LBN heart grafts in pre- 
treated animals. 
Tolerant Lewis recipients bearing two beating 
LBN hearts normally rejected skin allografts (mean 
8.4 days) from the same donor strain (LBN). Rejec- 
tion of the skin graft had no effect on the heart 
grafts. 
Discussion 
Donor-specific unresponsiveness in the absence 
of immunosuppressive agents is a goal in heart and 
other organ transplantation. I trathymic noculation 
with donor splenocyte alloantigens i  effective in 
producing tolerance to cardiac allografts. In the 
experiments reported here, tolerance to cardiac 
allografts was not affected by rechallenge with grafts 
from either the donor strain or a third-party strain. 
These data show that intrathymic pretreatment can 
produce specific tolerance to a cardiac allograft and 
that this tolerance is permanent. 
Several potential mechanisms could be responsi- 
ble for generating the tolerance observed in our 
model. One likely possibility is clonal deletion of 
alloreactive T cells. Clonal deletion is an important 
mechanism in immunologic development. 2 The in- 
jection of cells bearing alloantigens into the thymus 
changes the thymic microenvironment. ALS elimi- 
nates mature T cells, and the subsequent develop- 
ment of new T cells in the altered thymus now takes 
place in the presence of foreign antigen, which is 
reinterpreted as a self-antigen. Clones reactive to 
the alloantigen might therefore be eliminated, pro- 
ducing clonal deletion and thus tolerance to a 
subsequent graft. Our findings are consistent with 
this mechanism because subsequent donor strain 
grafts are not rejected but third-party grafts are. 
This reaction rules out a nonspecific suppressor 
mechanism. 
These experiments also demonstrated that intra- 
thymic injection of splenocyte alloantigens induced 
a state of donor-specific tolerance that allowed 
indefinite cardiac allograft survival but failed to 
produce prolonged skin allograft survival in the 
same recipient animals. These results suggest hat 
non-MHC antigens or special tissue antigens exist 
on the skin and are not expressed either on the 
splenocytes injected into thymic environment or on 
cardiac cells. If these antigens are not introduced 
into the thymus, they cannot take part in thymic 
recognition events that produce tolerance to tissue 
antigens. Whatever the mechanism of tolerance 
induction in this model, it appears that such non- 
MHC antigens or special skin antigens may account 
for the tissue specificity of the tolerance produced 
by intrathymic pretreatments. 
These studies show that tolerance induced to a 
cardiac allograft by intrathymic pretreatment is du- 
rable and specific for donor strain and tissue type 
(heart vs skin). Intrathymic pretreatment thus ap- 
pears to produce a permanent alteration in immune 
response to donor tissue. These studies also suggest 
that non-MHC antigens or special antigens may 
account for the tissue specificity of the tolerance 
produced by intrathymic treatment in allotransplan- 
ration. 
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